Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for tau-protein kinase activity (biogroup)
Most Correlated Studies
- L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
- L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
- L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
Most Relevant Literature
- Changes in adiponectin and inflammatory genes in response to hormonal imbalances in female mice and …
- Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies …
- Temperature-sensitive cellular mutant for expression of mRNA from murine retrovirus.
- The expression and properties of polyoma virus middle-T antigen in simian cells.
Most Relevant Clinical Trials
- A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Adva…
- Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Ra…
- A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Sig…
- A Dose Escalation/Expansion Study of LDK378 in Patients With Tumors Characterized by Genetic Abnorma…
- Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in…
